The global molecular imaging market would reach US$ 5,437.2 million by 2023. The market is anticipated to grow at a compound annual growth rate (CAGR) of 11.0% and generate US$ 15,457.48 million during the forecast period. The global rise in the prevalence of chronic illness is responsible for the market’s expansion.
The need for accurate and timely diagnoses is paramount in combating these complex diseases. Molecular imaging techniques offer a powerful solution, enabling physicians to detect abnormalities at a molecular level, often before conventional anatomical imaging methods can. This early detection window proves crucial in initiating effective treatment plans and improving patient outcomes.
Claim Your Exclusive Report Sample Preview: https://www.futuremarketinsights.com/reports/sample/rep-gb-724
Molecular imaging offers a unique perspective on biological processes at the molecular level, enabling healthcare professionals to identify diseases in their earliest stages. This leads to more effective treatment strategies and improved patient outcomes. Furthermore, the rapid advancements in molecular imaging technology are continuously enhancing its capabilities, further propelling market expansion.
Key Takeaways:
- In 2022, North America’s molecular imaging market expanded, with a CAGR of 35.1%.
- In 2022, the United States developed the molecular imaging business with a share of 22.6%.
- The molecular imaging market grew considerably to US$ 4,855.5 million in 2022.
- The molecular imaging market expanded with a CAGR of 9.3% between 2018 to 2022.
- By 2033, China’s molecular imaging market is projected to develop with a CAGR of 10.3%.
- By 2033, India’s molecular imaging industry is projected to expand with a CAGR of 11%.
- Japan’s molecular imaging industry grew significantly, with a 3.6% share in 2022.
- Australia’s molecular imaging market is likely to expand with a CAGR of 12.7% by 2033.
- Germany’s molecular imaging business grew, with a share of 6.9% in 2022
- In 2022, based on modality, SPECT dominated the market, with a share of 23.5%.
- In 2022, the hospital’s segment led the market, with a share of 56.5%, based on the end user.
Learn About Our Methodology Structure: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-724
Key players:
- Hermes Medical Solutions
- Bruker Corporation
- GE Company
- Fujifilm Holdings Corp.
- Koninklijke Philips N.V.
- Siemens AG
- Toshiba Medical System Corp.
- Mirada Medical Limited
- Carestream Health, Inc.
- Esaote SpA
- Positron Corporation
- Medisco Ltd.
- Hitachi Medical Corp.
- MIM Software Inc.
Key segments :
By Modality:
- Molecular Ultrasound Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Nuclear Magnetic Resonance (NMR) Spectrometer
- Hybrid Products
By Application:
- Cardiovascular
- Neurology
- Oncology
- Respiratory
- Gastrointestinal
By End Users:
- Hospitals
- Diagnostic Imaging Centres
- Ambulatory Surgical Centres
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa (MEA)
Get Full Market Analysis Now: Purchase Now to Access: https://www.futuremarketinsights.com/checkout/724
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube